Sreenivasa Nattam
Fort Wayne Medical Institute(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Lung Cancer Research Studies
Most-Cited Works
- → Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL(2018)938 cited
- → Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study(2014)582 cited
- → Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer(2015)532 cited
- → Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology(2008)493 cited
- → Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer(2005)458 cited
- → Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study(2009)271 cited
- → Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation(2003)205 cited
- → Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75(2011)189 cited
- → Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer(2019)187 cited
- → A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck(2012)113 cited